Medical Science Liaison-South Central

The role

The Medical Science Liaison will build and execute territory engagement plans to establish relationships with external stakeholders and support medical strategy. This field-based role serves as a scientific expert and communication conduit between the clinical community and the internal team.

What you will do

• Identify, develop, and maintain collaborative relationships with key opinion leaders, speakers and investigators
• Stay informed of medical and scientific developments in Dermatology and related fields
• Support national and regional scientific congresses with KOL engagements, poster/abstract coverage, booth staffing, and company debriefs
• Provide internal stakeholders with feedback and actionable insights from interactions with HCPs
• Identify, engage, and support investigators and site staff of clinical research sites

Required qualifications

• Advanced degree in life sciences (PharmD, PhD, MD/DO, MSN, NP/DNP, DMS/PA or equivalent)
• Minimum of 5 years relevant clinical and/or industry experience
• Prior experience as a field medical science liaison
• Relevant therapeutic area knowledge, understanding of drug development process, clinical trial design, safety monitoring, and regulatory landscape
• Self-driven and ability to work independently with minimal direct supervision
• Exceptional communication and time management skills
• Must live within applicable territory with convenient access to national/international airport
• Business travel up to 75% of time

Nice to have

• experience in Dermatology
• experience in Dermatology preferred
• Routine and tangible experience in a field medical role working with CRO and clinical operations

Benefits

• Competitive salary and benefits package
• A chance to be part of a vibrant startup culture
• A supportive and inclusive team environment
• Opportunities for professional growth and development

About the company

Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. The company is advancing a proprietary portfolio of potentially best-in-class antibodies targeting plaque psoriasis and other dermatologic and inflammatory diseases.